JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB230368

BAY-299, TAF1 and BRD1 inhibitor

Be the first to review this product! Submit a review

|

(1 Publication)

MW 429.5 Da, Purity >98%. Potent and selective bromodomain inhibitor of TAF1 (IC50 = 8-13 nM) and BRD1 (IC50 = 6-67 nM). More than 30-fold selective versus BRD9 and ATAD2. More than 300-fold selective versus BRD4. Inhibits BRD1 (IC50 = 0.58 μM) and TAF1 (IC50 = 0.9 μM) binding to Histone H4 in cell-based assays; also inhibits BRD1 (IC50 = 0.83 μM) and TAF1 (IC50 = 1.4 μM) binding to Histone H3.3.

View Alternative Names

Bromodomain and PHD finger containing protein 3, Bromodomain and PHD finger containing, 3, KIAA1286

1 Images
Chemical Structure - BAY-299, TAF1 and BRD1 inhibitor (AB230368)
  • Chemical Structure

Lab

Chemical Structure - BAY-299, TAF1 and BRD1 inhibitor (AB230368)

2D chemical structure image of ab230368, BAY-299, TAF1 and BRD1 inhibitor

Key facts

CAS number

2080306-23-4

Purity

>98%

Form

Solid

form

Molecular weight

429.5 Da

Molecular formula

C<sub>2</sub><sub>5</sub>H<sub>2</sub><sub>3</sub>N<sub>3</sub>O<sub>4</sub>

PubChem

122705990

Nature

Synthetic

Solubility

100 mM in DMSO

Biochemical name

6-(3-Oxidanylpropyl)-2-(1,3,6-Trimethyl-2-Oxidanylidene-Benzimidazol-5-Yl)benzo[de]isoquinoline-1,3-Dione

Biological description

Potent and selective bromodomain inhibitor of TAF1 (IC50 = 8-13 nM) and BRD1 (IC50 = 6-67 nM). More than 30-fold selective versus BRD9 and ATAD2. More than 300-fold selective versus BRD4. Inhibits BRD1 (IC50 = 0.58 μM) and TAF1 (IC50 = 0.9 μM) binding to Histone H4 in cell-based assays; also inhibits BRD1 (IC50 = 0.83 μM) and TAF1 (IC50 = 1.4 μM) binding to Histone H3.3.

Canonical smiles

CC1=CC2=C(C=C1N3C(=O)C4=C5C(=C(C=C4)CCCO)C=CC=C5C3=O)N(C(=O)N2C)C

InChi

InChI=1S/C25H23N3O4/c1-14-12-20-21(27(3)25(32)26(20)2)13-19(14)28-23(30)17-8-4-7-16-15(6-5-11-29)9-10-18(22(16)17)24(28)31/h4,7-10,12-13,29H,5-6,11H2,1-3H3

InChiKey

OFWWWKWUCDUISA-UHFFFAOYSA-N

IUPAC Name

6-(3-hydroxypropyl)-2-(1,3,6-trimethyl-2-oxobenzimidazol-5-yl)benzo[de]isoquinoline-1,3-dione

style
left-column
style
left-column

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
style
left-column
style
left-column
style
left-column

Product protocols

style
left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Biochemistry 61:1774-1789 PubMed35976792

2022

Molecular Insights into the Recognition of Acetylated Histone Modifications by the BRPF2 Bromodomain.

Applications

Unspecified application

Species

Unspecified reactive species

Soumen Barman,Anirban Roy,Jyotirmayee Padhan,Babu Sudhamalla
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Proteins & Peptides

AB270062

Recombinant human IGF1 protein (Active)

Premium Bioactive

Functional Studies - Recombinant human IGF1 protein (Active) (AB270062)

  • 5
  • 1
Reagents, Controls & Accessories

AB171532

Phosphate Buffered Saline (PBS) Casein ELISA Reagent

  • 0
  • 0
Reagents, Controls & Accessories

AB210900

Stop Solution 1X

  • 0
  • 0
Primary Antibodies

AB267492

Anti-RAB8A (phospho S111) antibody [MJF-R27-30]

RabMAb|Recombinant|KO Validated

Western blot - Anti-RAB8A (phospho S111) antibody [MJF-R27-30] (AB267492)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com